Formosa Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 12, 2022 at 05:05 am EDT
Share
Formosa Laboratories, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 838.22 million compared to TWD 827.34 million a year ago. Net loss was TWD 8.53 million compared to net income of TWD 744.63 million a year ago. Basic loss per share from continuing operations was TWD 0.07 compared to basic earnings per share from continuing operations of TWD 6.86 a year ago. Diluted loss per share from continuing operations was TWD 0.07 compared to diluted earnings per share from continuing operations of TWD 6.14 a year ago.
For the six months, sales was TWD 1,673.16 million compared to TWD 1,563.62 million a year ago. Net loss was TWD 408.89 million compared to net income of TWD 1,810.44 million a year ago. Basic loss per share from continuing operations was TWD 3.4 compared to basic earnings per share from continuing operations of TWD 16.7 a year ago. Diluted loss per share from continuing operations was TWD 3.4 compared to diluted earnings per share from continuing operations of TWD 14.91 a year ago.
Formosa Laboratories, Inc. is a Taiwan-based company principally engaged in the development, production and distribution of ultraviolet (UV)-proof active ingredients, bulk pharmaceutical chemicals, antibody drug conjugates, as well as the provision of customized services. The Company primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The Company distributes its products to Europe, the Americas, Asia and other markets.